COMMUNIQUÉS West-GlobeNewswire

Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients
25/01/2018
CHICAGO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, today announced a [...]
UPDATE -- DLT Resolution to acquire 80% of fast growing Canadian start-up A.J.D. Data Services Ltd.
25/01/2018
LAS VEGAS, NV, Jan. 25, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC: DLTI), a blockchain technology and data services company providing distributed ledger technology that currently services the healthcare and [...]
Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology
25/01/2018
Hamilton, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Mariner Endosurgery Inc., an innovative Canadian medical device company leading commercialization of computer-assisted medical devices for laparoscopic surgeries, announced [...]
American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
25/01/2018
ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure [...]
UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
25/01/2018
VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Please note this is an Official Company News Release. Breathtec Biomedical Inc. (CSE:BTH) (CNSX: BTH ) (FRANKFURT: BTI ) (OTCQB:BTHCF) (the “Company”) is [...]
Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split
25/01/2018
FREMONT, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
ArmadaCare Announces a New Suite of Supplemental Insurance Products
25/01/2018
HUNT VALLEY, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ArmadaCare has launched a new suite of supplemental insurance products, further strengthening its market-leading position in the group targeted supplemental health [...]
Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206
25/01/2018
MORRISVILLE, N.C., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that the first patient has been dosed in the Company's Phase 2 clinical trial to evaluate [...]
Albireo Prices $65.0 Million Public Offering of Common Stock
25/01/2018
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of its [...]
Golden Leaf Subsidiary, Medical Marijuana Group, Receives First Shipment of Genetics to its Grow Facility in St. Thomas, Ontario
25/01/2018
TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that its [...]
Marrone Bio Innovations Announces Distribution Partnership in the Philippines
25/01/2018
DAVIS, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
25/01/2018
NORCROSS, Ga., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins to treat non-alcoholic steatohepatitis (NASH) cirrhosis [...]
Hemispherx Announces Data Presentation on the Potential for Ampligen to Improve Cancer Outcomes with Checkpoint Inhibitors
25/01/2018
MIAMI, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announced that Pawel Kalinski, MD, vice chairman for translational research and professor of [...]
Skyline Medical Announces Corporate Name Change to Precision Therapeutics
25/01/2018
MINNEAPOLIS, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ: SKLN ) (“Skyline” or the “Company”) today announced it will change its name to Precision Therapeutics Inc., effective February 1, 2018. The new [...]
Abattis Announces Successful Completion of Acquisition of Green Tree Therapeutics
25/01/2018
VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (OTC: ATTBF) is pleased to announce that, further to its news releases dated December 22 [...]
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
25/01/2018
MIAMI, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital [...]
Advanced Bifurcation Systems Appoints Industry Veteran Thomas O’Neill to Board of Directors
25/01/2018
LOS ANGELES, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of [...]
Humanigen CEO to Present at NobleCon14, BIO CEO Investor Conferences
25/01/2018
BRISBANE, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology [...]
Actinium Pharmaceuticals Issues Letter to Investors Providing Company Update and Outlook for 2018
25/01/2018
Strong finish to 2017 sets stage for series of value enhancing milestones in 2018 NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced [...]

Pages